Cargando…

A gene-based risk score model for predicting recurrence-free survival in patients with hepatocellular carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) remains the most frequent liver cancer, accounting for approximately 90% of primary liver cancers worldwide. The recurrence-free survival (RFS) of HCC patients is a critical factor in devising a personal treatment plan. Thus, it is necessary to accurately f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Wenhua, Wang, Lingchen, Xie, Xinsheng, Yan, Yehong, Li, Yue, Lu, Quqin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786458/ https://www.ncbi.nlm.nih.gov/pubmed/33402113 http://dx.doi.org/10.1186/s12885-020-07692-6

Ejemplares similares

A Five-LLPS Gene Risk Score Prognostic Signature Predicts Survival in Hepatocellular Carcinoma
por: Lai, Wenwen, et al.
Publicado: (2023)

A 5‐gene prognostic nomogram predicting survival probability of glioblastoma patients
por: Wang, Lingchen, et al.
Publicado: (2019)

Identification of potential key genes and pathways in hepatitis B virus-associated hepatocellular carcinoma by bioinformatics analyses
por: Zhang, Xiang, et al.
Publicado: (2020)

Construction and validation of a 6-gene nomogram discriminating lung metastasis risk of breast cancer patients
por: Wang, Lingchen, et al.
Publicado: (2020)

FOXM1 promotes hepatocellular carcinoma progression by regulating KIF4A expression
por: Hu, Guohui, et al.
Publicado: (2019)

Aberrantly activated Gli2-KIF20A axis is crucial for growth of hepatocellular carcinoma and predicts poor prognosis
por: Shi, Chao, et al.
Publicado: (2016)

A Novel Nomogram Model to Predict the Recurrence-Free Survival and Overall Survival of Hepatocellular Carcinoma
por: Zhang, Shu-Wen, et al.
Publicado: (2022)

Anatomical sites (Takasaki’s segmentation) predicts the recurrence-free survival of hepatocellular carcinoma
por: Qin, Wei, et al.
Publicado: (2021)

A genomic-clinical nomogram predicting recurrence-free survival for patients diagnosed with hepatocellular carcinoma
por: Kong, Junjie, et al.
Publicado: (2019)

The critical role of dysregulated Hh-FOXM1-TPX2 signaling in human hepatocellular carcinoma cell proliferation
por: Wang, Yiting, et al.
Publicado: (2020)

Modified preoperative score to predict disease-free survival for hepatocellular carcinoma patients with surgical resections
por: Lai, Yin, et al.
Publicado: (2022)

Tumor repressor gene chondroadherin oppose migration and proliferation in hepatocellular carcinoma and predicts a good survival
por: Deng, Xiaorong, et al.
Publicado: (2017)

Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma
por: Gu, Jing-Xian, et al.
Publicado: (2019)

Nomograms for Predicting Hepatocellular Carcinoma Recurrence and Overall Postoperative Patient Survival
por: Ma, Lidi, et al.
Publicado: (2022)

Development of Prognostic Evaluation Model to Predict the Overall Survival and Early Recurrence of Hepatocellular Carcinoma
por: Zhong, Yue, et al.
Publicado: (2021)

Radiofrequency ablation of hepatocellular carcinoma: a meta-analysis of overall survival and recurrence-free survival
por: Gardini, Andrea Casadei, et al.
Publicado: (2018)

Co-expression of PKM2 and TRIM35 predicts survival and recurrence in hepatocellular carcinoma
por: Chen, Zhiao, et al.
Publicado: (2014)

Genetic variants of cell cycle pathway genes predict disease‐free survival of hepatocellular carcinoma
por: Liu, Shun, et al.
Publicado: (2017)

Novel Gene Signatures Promote Epithelial-Mesenchymal Transition (EMT) in Glucose Deprivation-Based Microenvironment to Predict Recurrence‐Free Survival in Hepatocellular Carcinoma
por: Huang, Yuan, et al.
Publicado: (2023)

Comparisons of recurrence-free survival and overall survival between microwave versus radiofrequency ablation treatment for hepatocellular carcinoma: A multiple centers retrospective cohort study with propensity score matching
por: Du, Shibin, et al.
Publicado: (2020)

A 6 transcription factors-associated nomogram predicts the recurrence-free survival of thyroid papillary carcinoma
por: Wang, Tao, et al.
Publicado: (2021)

Factors predicting survival after post-transplant hepatocellular carcinoma recurrence
por: Toso, Christian, et al.
Publicado: (2012)

Molecular Scoring of Hepatocellular Carcinoma for Predicting Metastatic Recurrence and Requirements of Systemic Chemotherapy
por: Nishida, Naoshi, et al.
Publicado: (2018)

Risk Factors and Post-Resection Independent Predictive Score for the Recurrence of Hepatitis B-Related Hepatocellular Carcinoma
por: Hung, Ivan Fan-Ngai, et al.
Publicado: (2016)

Risk Group Stratification for Recurrence-Free Survival and Early Tumor Recurrence after Radiofrequency Ablation for Hepatocellular Carcinoma
por: Cha, Dong Ik, et al.
Publicado: (2023)

The prognostic significance of inflammation-immunity-nutrition score on postoperative survival and recurrence in hepatocellular carcinoma patients
por: Liang, Yuxin, et al.
Publicado: (2022)

Risk Scoring System based on lncRNA Expression for Predicting Survival in Hepatocellular Carcinoma with Cirrhosis
por: Ye, Jiaxiang, et al.
Publicado: (2020)

The Glasgow Prognostic Score, an inflammation based prognostic score, predicts survival in patients with hepatocellular carcinoma
por: Kinoshita, Akiyoshi, et al.
Publicado: (2013)

A Molecular Hepatocellular Carcinoma Prognostic Score System Precisely Predicts Overall Survival of Hepatocellular Carcinoma Patients
por: Jia, Jie, et al.
Publicado: (2022)

A Five-Gene Signature for Recurrence Prediction of Hepatocellular Carcinoma Patients
por: Wang, Zeyu, et al.
Publicado: (2020)

Adjuvant therapy with Jianpi Huayu decoction improves overall and recurrence-free survival after hepatectomy for hepatocellular carcinoma: a retrospective propensity score-matching study
por: Luo, Rui, et al.
Publicado: (2023)

Development of a clinical scoring model to predict the overall and relapse‑free survival of patients with hepatocellular carcinoma following a hepatectomy
por: Deng, Wanyu, et al.
Publicado: (2023)

Gene expression in nontumoral liver tissue and recurrence-free survival in hepatitis C virus-positive hepatocellular carcinoma
por: Tsuchiya, Masato, et al.
Publicado: (2010)

Development and verification of a nomogram for prediction of recurrence‐free survival in clear cell renal cell carcinoma
por: Chen, Yuanlei, et al.
Publicado: (2019)

A methylomics‐associated nomogram predicts recurrence‐free survival of thyroid papillary carcinoma
por: Chen, Hengyu, et al.
Publicado: (2020)

External Validation of the RETREAT Score for Prediction of Hepatocellular Carcinoma Recurrence after Liver Transplantation
por: van Hooff, Maria C., et al.
Publicado: (2022)

Erratum to: Factors predicting survival after post-transplant hepatocellular carcinoma recurrence
por: Toso, Christian, et al.
Publicado: (2013)

Integrated nomograms to predict overall survival and recurrence-free survival in patients with combined hepatocellular cholangiocarcinoma (cHCC) after liver resection
por: Wang, Tao, et al.
Publicado: (2020)

Development of a deep pathomics score for predicting hepatocellular carcinoma recurrence after liver transplantation
por: Qu, Wei-Feng, et al.
Publicado: (2023)

Recurrence‐associated gene signature optimizes recurrence‐free survival prediction of colorectal cancer
por: Tian, Xianglong, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_uvj21a5jjdtsfs2tfc3gae4oj2